Actinobacteria-derived secondary metabolites: a potential reservoir of antifungal agents
Abstract
Fungi are recognized as one of the most perilous agents, possessing a detrimental capability due to their emerging pathogenesis, rapid disease progression, and increasing resistance to numerous medications. Although it accounts for a large number of severe effects, studies on fungus-related diseases in humans, plants, and animals are relatively less compared to bacterial infections. Fungi primarily induce diseases in hosts through two key mechanisms: direct invasion or damage to host tissues, manifesting as pathogenic symptoms, and the production of mycotoxins, which, when ingested or absorbed, lead to disease manifestation . Actinobacteria are renowned as a rich source of bioactive molecules, which possess a natural ability to counteract diverse fungal pathogens. These potential actinobacteria are extensively exploited to extract bioactive secondary metabolites, which are then used to formulate antifungal products. This review emphasizes the catastrophic impacts of fungal pathogens in plants, animals, and humans. It also highlights the antifungal metabolites produced by various actinobacteria inhabiting different environmental niches along with their target fungal pathogens, including the different antagonistic mechanisms involved.